NCT02393573View on ClinicalTrials.gov

Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism

NATerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Pre-DiabetesMajor Lung or Abdominal SurgeryInsulin Resistance
Interventions
DRUG

Metformin

Patients will take metformin for two weeks before Surgery and 2 days after the surgery

DRUG

Placebo

Patients will take Placebo pills for two weeks before Surgery and 2 days after the surgery

Trial Locations (1)

H3G 1A4

Montreal General Hospital, Montreal

Sponsors

Collaborators (2)

Mitacs
Medtronic - MITG
All Listed Sponsors
collaborator

Mitacs

INDUSTRY

collaborator

Medtronic - MITG

INDUSTRY

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT02393573 - Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism | Biotech Hunter | Biotech Hunter